In this interview, Neil Spooner (Spooner Bioanalytical Solutions, Hertford, UK) explains some of the recent developments in microsampling technology and the challenges with regulation. He discusses his work in patient-centred screening methods and the technologies he hopes to see in the future.
About the author:
Neil Spooner has extensive experience in the quantitative bioanalysis of drugs, metabolites and biomarkers in the pharmaceutical industry and contract research organisations in the UK and USA. In over 20 years of industrial practice, he has led groups operating in discovery and regulation of clinical and pre-clinical quantitative bioanalysis and metabolite identification.
Neil Spooner, is the Senior Editor of Bioanalysis, the leading journal for the field of regulated quantitative bioanalysis. In addition, he is a Senior Visiting Research Fellow at the School of Life and Medical Sciences, University of Hertfordshire (UK)
Video originally published on Bioanalysis Zone, a digital platform from the Future Science Group that aims to advance the field of bioanalysis by increasing subject understanding and sharing of knowledge across barriers to unite the bioanalytical community.